Paul V. Radspinner

Biography

Mr. Radspinner is co-founder, President and Chief Executive Officer of FluGen Inc. which he co-founded with Drs. Yoshihiro Kawaoka and Gabriele Neumann in June of 2007. With Mr. Radspinner as President & CEO FluGen has raised over $25 million in capital and completed its first-in-man study of M2SR “RedeeFlu” earlier this year. After completing his MBA at Northwestern University’s Kellogg Graduate School of Management he spent over 15 years in management roles overseeing international pharmaceutical operations, marketing and business development with Eli Lilly and Company. After his time at Lilly he managed the pharmaceuticals portfolio including Vitamin D analogs at the Wisconsin Alumni Research Foundation (WARF) for the University of Wisconsin-Madison. Mr. Radspinner entered the Madison biotech scene when he took on the role of Vice President of Business Development for Deltanoid Pharmaceuticals, Inc. and then started FluGen. In 2008 Mr. Radspinner was elected to the Board of Directors for BioForward, the Wisconsin state biotechnology organization where he served as President. Mr. Radspinner is a member of the Boards of Directors for Plumb Pharmaceuticals, Pan Genome Sciences and Co-D Therapeutics.

Research Interest

 Pharmaceutical Operations, Marketing and Business Development